Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis

Hyeon-Jeong Lee; Hye Jin Jang; Won-Il Choi; Joonsung Joh; Junghyun Kim; Jungeun Park; Miyoung Choi

doi:10.4266/acc.2022.01424.e1

Articles

Page Path: HOME > Acute Crit Care > Volume 38(4); 2023 > Article

Corrigendum Meta-analysis Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis: Hyeon-Jeong Lee¹, Hye Jin Jang², Won-Il Choi², Joonsung Joh³, Junghyun Kim³, Jungeun Park¹, Miyoung Choi¹; Acute and Critical Care 2023;38(4):516-516.
DOI: https://doi.org/10.4266/acc.2022.01424.e1
Published online: November 20, 2023

¹Division of Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Korea

²Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Myongji Hospital, Hanyang University, Goyang, Korea

³Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, National Medical Center, Seoul, Korea

Corresponding author: Miyoung Choi Division of Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Health and Welfare Administration Town, 400 Neungdong-ro, Gwangjin-gu, Seoul 04933, Korea Tel: +82-2-2174-2867, Fax: +82-2-747-4916, Email: myhams95@gmail.com

*These authors contributed equally to this work.

• Received: November 28, 2023 • Accepted: November 20, 2023

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

580 Views
28 Download

Full Article

Download PDF

This corrects the article "Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis" on page 160.

Acute and Critical Care 2023;38:160-71

https://doi.org/10.4266/acc.2022.01424

In the article entitled “Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis,” there was an error in Results section of the abstract. In the sentence “In the severe patients, the incidence of thromboembolic and bleeding events in the therapeutic or intermediate.” should be:

“In the severe group, the incidence of thromboembolic and bleeding events in the therapeutic and prophylaxis groups was not statistically different.”

Furthermore, the city of Myongji Hospital was inadvertently omitted, and it should be included as “Goyang.”

Figure & Data

References

Citations

Citations to this article as recorded by

PubReader
ePub Link

Cite

CITE: export Copy Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis

Acute Crit Care. 2023;38(4):516-516. Published online November 28, 2023

DOI: https://doi.org/10.4266/acc.2022.01424.e1

XML Download

We recommend

Related articles